Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Amélie Charbrier"'
Autor:
Anne-Marie C. Dingemans, Ernst-Jan M. Speel, Lynnette Fernandez-Cuesta, James D. McKay, Matthieu Foll, Amélie Charbrier, Esther C. van den Broek, Ronald Damhuis, Egbert F. Smit, Harry J.M. Groen, Michael den Bakker, Robert Jan van Suylen, Erik Thunnissen, Noémie Leblay, Jules L. Derks
FISH analysis datafile
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::544a0c4071166a77185e5ec5ceb7a292
https://doi.org/10.1158/1078-0432.22462046.v1
https://doi.org/10.1158/1078-0432.22462046.v1
Autor:
Anne-Marie C. Dingemans, Ernst-Jan M. Speel, Lynnette Fernandez-Cuesta, James D. McKay, Matthieu Foll, Amélie Charbrier, Esther C. van den Broek, Ronald Damhuis, Egbert F. Smit, Harry J.M. Groen, Michael den Bakker, Robert Jan van Suylen, Erik Thunnissen, Noémie Leblay, Jules L. Derks
Supplemental legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::213fcfa7543dec606eb7b6e23bca2e88
https://doi.org/10.1158/1078-0432.22462052.v1
https://doi.org/10.1158/1078-0432.22462052.v1
Autor:
Anne-Marie C. Dingemans, Ernst-Jan M. Speel, Lynnette Fernandez-Cuesta, James D. McKay, Matthieu Foll, Amélie Charbrier, Esther C. van den Broek, Ronald Damhuis, Egbert F. Smit, Harry J.M. Groen, Michael den Bakker, Robert Jan van Suylen, Erik Thunnissen, Noémie Leblay, Jules L. Derks
A) Overall survival according to the original established diagnosis in patients included in the panel-consensus revision (n=232). B) Overall survival according to the panel-consensus diagnoses. Abbreviations: NSCLC NED, non-small cell lung carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ca06cf84b1294a427788152c022074b
https://doi.org/10.1158/1078-0432.22462061.v1
https://doi.org/10.1158/1078-0432.22462061.v1
Autor:
Anne-Marie C. Dingemans, Ernst-Jan M. Speel, Lynnette Fernandez-Cuesta, James D. McKay, Matthieu Foll, Amélie Charbrier, Esther C. van den Broek, Ronald Damhuis, Egbert F. Smit, Harry J.M. Groen, Michael den Bakker, Robert Jan van Suylen, Erik Thunnissen, Noémie Leblay, Jules L. Derks
Purpose: Previous genomic studies have identified two mutually exclusive molecular subtypes of large-cell neuroendocrine carcinoma (LCNEC): the RB1 mutated (mostly comutated with TP53) and the RB1 wild-type groups. We assessed whether these subtypes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d5338f5b622fd10e7b4c696c7a52608
https://doi.org/10.1158/1078-0432.c.6524990.v1
https://doi.org/10.1158/1078-0432.c.6524990.v1
Autor:
Anne-Marie C. Dingemans, Ernst-Jan M. Speel, Lynnette Fernandez-Cuesta, James D. McKay, Matthieu Foll, Amélie Charbrier, Esther C. van den Broek, Ronald Damhuis, Egbert F. Smit, Harry J.M. Groen, Michael den Bakker, Robert Jan van Suylen, Erik Thunnissen, Noémie Leblay, Jules L. Derks
Pathology review data and next-generation sequencing datafile.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3220056d887f1edb927bf503a6d0fa38
https://doi.org/10.1158/1078-0432.22462049
https://doi.org/10.1158/1078-0432.22462049
Autor:
Anne-Marie C. Dingemans, Ernst-Jan M. Speel, Lynnette Fernandez-Cuesta, James D. McKay, Matthieu Foll, Amélie Charbrier, Esther C. van den Broek, Ronald Damhuis, Egbert F. Smit, Harry J.M. Groen, Michael den Bakker, Robert Jan van Suylen, Erik Thunnissen, Noémie Leblay, Jules L. Derks
Progression-free survival for subtypes of chemotherapy in panel-consensus LCNEC with A) RB1 wild-type*; B) RB1 mutation; C) H-score {greater than or equal to}50 for RB1* IHC; D) H-score
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29c2b9a6c131b087d80a8158831e7ab2
https://doi.org/10.1158/1078-0432.22462058.v1
https://doi.org/10.1158/1078-0432.22462058.v1
Autor:
Anne-Marie C. Dingemans, Ernst-Jan M. Speel, Lynnette Fernandez-Cuesta, James D. McKay, Matthieu Foll, Amélie Charbrier, Esther C. van den Broek, Ronald Damhuis, Egbert F. Smit, Harry J.M. Groen, Michael den Bakker, Robert Jan van Suylen, Erik Thunnissen, Noémie Leblay, Jules L. Derks
Original magnification overview x10 and insert x40 in panel-consensus diagnosed LCNECs. A) No nuclear staining for RB1 (13A10) in LCNEC mutated for RB1 and TP53 genes. B) Nuclear and cytoplasmatic staining for P16. C) Nuclear staining for RB1 protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::111f39123f54751d973c65a2b0e7845e
https://doi.org/10.1158/1078-0432.22462055.v1
https://doi.org/10.1158/1078-0432.22462055.v1
Autor:
Ronald A M Damhuis, Ernst-Jan M. Speel, Erik Thunnissen, Egbert F. Smit, Robert-Jan van Suylen, Harry J.M. Groen, Esther C. van den Broek, Jules L. Derks, Noémie Leblay, Anne-Marie C. Dingemans, Lynnette Fernandez-Cuesta, Amélie Charbrier, James McKay, Matthieu Foll, Michael A. den Bakker
Publikováno v:
Clinical Cancer Research, 24(1), 33-42. American Association for Cancer Research Inc.
Clinical Cancer Research, 24(1), 33-42. AMER ASSOC CANCER RESEARCH
PALGA-Group 2018, ' Molecular subtypes of pulmonary large-cell neuroendocrine carcinoma predict chemotherapy treatment outcome ', Clinical Cancer Research, vol. 24, no. 1, pp. 33-42 . https://doi.org/10.1158/1078-0432.CCR-17-1921
Clinical Cancer Research, 24(1), 33-42. AMER ASSOC CANCER RESEARCH
PALGA-Group 2018, ' Molecular subtypes of pulmonary large-cell neuroendocrine carcinoma predict chemotherapy treatment outcome ', Clinical Cancer Research, vol. 24, no. 1, pp. 33-42 . https://doi.org/10.1158/1078-0432.CCR-17-1921
Purpose: Previous genomic studies have identified two mutually exclusive molecular subtypes of large-cell neuroendocrine carcinoma (LCNEC): the RB1 mutated (mostly comutated with TP53) and the RB1 wild-type groups. We assessed whether these subtypes